22 May 2013
Keywords: nice, backs, nhs, use, roche, xenical, takeda
Article | 09 March 2001
The National Institute for Clinical Excellence has stated that Roche'santiobesity treatment Xenical (orlistat) should remain available for use
on the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 March 2001
8 March 2001
21 May 2013
© 2013 thepharmaletter.com